{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:14:53Z","timestamp":1790194493725,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jaad.2016.02.1229","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T22:53:34Z","timestamp":1463180014000},"page":"516-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study"],"prefix":"10.1016","volume":"75","author":[{"given":"Sebastian","family":"Podlipnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1608-8820","authenticated-orcid":false,"given":"Cristina","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Arguis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Olondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Vilana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Rull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Vidal-Sicart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vilalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Conill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-9745","authenticated-orcid":false,"given":"Susana","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2016.02.1229_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjc.6602321","article-title":"Years of life lost (YLL) from cancer is an important measure of population burden\u2013and should be considered when allocating research funds","volume":"92","author":"Burnet","year":"2005","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.jaad.2016.02.1229_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2004.05708.x","article-title":"Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma","volume":"150","author":"Lens","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.02.1229_bib3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2340\/00015555-1997","article-title":"Melanoma incidence increases in the elderly of Catalonia but not in the younger population: effect of prevention or consequence of immigration?","volume":"95","author":"Puig","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2016.02.1229_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ctrv.2014.06.012","article-title":"Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma","volume":"40","author":"McDermott","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"26","key":"10.1016\/j.jaad.2016.02.1229_bib5","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jaad.2016.02.1229_bib6","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2016.02.1229_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2016.02.1229_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2016.02.1229_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2016.02.1229_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/CMR.0b013e32833716f9","article-title":"Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?","volume":"20","author":"Leiter","year":"2010","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.jaad.2016.02.1229_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40425-014-0040-2","article-title":"Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome","volume":"2","author":"Nishino","year":"2014","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jaad.2016.02.1229_bib12","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.8516","article-title":"Unraveling the prognostic heterogeneity in patients with advanced melanoma between Australia (OZ) and the United States (US): preliminary report of the PHAMOUS study","volume":"28","author":"Atkins","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2016.02.1229_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/1471-2407-11-328","article-title":"Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma","volume":"11","author":"Peric","year":"2011","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.jaad.2016.02.1229_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1470-2045(05)70283-7","article-title":"Follow-up in patients with localized primary cutaneous melanoma","volume":"6","author":"Francken","year":"2005","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.jaad.2016.02.1229_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.2003.01.091","article-title":"Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy","volume":"21","author":"Garbe","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2016.02.1229_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00000658-199505000-00014","article-title":"Melanoma recurrence surveillance. Patient or physician based?","volume":"221","author":"Shumate","year":"1995","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.jaad.2016.02.1229_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1245\/s10434-008-0238-y","article-title":"Method of detection of initial recurrence of stage II\/III cutaneous melanoma: analysis of the utility of follow-up staging","volume":"16","author":"Meyers","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2016.02.1229_bib18","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1245\/s10434-007-9347-2","article-title":"Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines","volume":"14","author":"Francken","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.jaad.2016.02.1229_bib19","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2252::AID-CNCR12>3.0.CO;2-Q","article-title":"Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma","volume":"86","author":"Poo-Hwu","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2016.02.1229_bib20","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/jdv.12602","article-title":"The utility of ancillary tests in monitoring cutaneous melanoma patients to detect visceral metastasis","volume":"29","author":"Ferreres","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2016.02.1229_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2010.09.772","article-title":"Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry","volume":"66","author":"Leiter","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2016.02.1229_bib22","doi-asserted-by":"crossref","first-page":"e57665","DOI":"10.1371\/journal.pone.0057665","article-title":"Hazard-rate analysis and patterns of recurrence in early stage melanoma: moving towards a rationally designed surveillance strategy","volume":"8","author":"Salama","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.jaad.2016.02.1229_bib23","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1200\/JCO.2009.26.2063","article-title":"Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines","volume":"28","author":"Romano","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2016.02.1229_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.critrevonc.2014.03.001","article-title":"Follow-up of patients with early breast cancer: is it time to rewrite the story?","volume":"91","author":"Puglisi","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jaad.2016.02.1229_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrurol.2015.313","article-title":"Active surveillance for prostate cancer: a narrative review of clinical guidelines","volume":"13","author":"Bruinsma","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"5","key":"10.1016\/j.jaad.2016.02.1229_bib26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bpobgyn.2014.04.008","article-title":"Which imaging technique should we use in the follow up of gynecological cancer?","volume":"28","author":"Testa","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.jaad.2016.02.1229_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000356044","article-title":"Is symptom-oriented follow-up still up to date?","volume":"8","author":"Mundhenke","year":"2013","journal-title":"Breast Care Basel Switz"},{"key":"10.1016\/j.jaad.2016.02.1229_bib28","unstructured":"US Department of Health and Human Services. Centers for Medicare and Medicaid Services. Physician Quality Reporting System. Available from: URL: http:\/\/www.cms.hhs.gov\/PQRI\/. Accessed January 16, 2016."},{"issue":"2","key":"10.1016\/j.jaad.2016.02.1229_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","article-title":"Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis","volume":"103","author":"Xing","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.jaad.2016.02.1229_bib30","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1586\/era.11.115","article-title":"New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB)","volume":"11","author":"Ulrich","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.jaad.2016.02.1229_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/bjc.2012.306","article-title":"Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis","volume":"107","author":"Weide","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2016.02.1229_bib32","first-page":"383","article-title":"Evaluating biomarkers in melanoma","volume":"4","author":"Karagiannis","year":"2015","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.jaad.2016.02.1229_bib33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/bjs.6347","article-title":"Follow-up schedules after treatment for malignant melanoma","volume":"95","author":"Francken","year":"2008","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.jaad.2016.02.1229_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamaophthalmol.2013.564","article-title":"Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma","volume":"131","author":"Wen","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.jaad.2016.02.1229_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejca.2005.10.008","article-title":"Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma","volume":"42","author":"M\u00fcller-Horvat","year":"2006","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"Suppl 4","key":"10.1016\/j.jaad.2016.02.1229_bib36","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.4103\/2152-7806.111298","article-title":"Imaging of brain metastases","volume":"4","author":"Fink","year":"2013","journal-title":"Surg Neurol Int"},{"issue":"11","key":"10.1016\/j.jaad.2016.02.1229_bib37","doi-asserted-by":"crossref","first-page":"e81624","DOI":"10.1371\/journal.pone.0081624","article-title":"Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy","volume":"8","author":"Weide","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jaad.2016.02.1229_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijc.27991","article-title":"Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein; plasmatic proteasomes and malignant melanoma","volume":"133","author":"Henry","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2016.02.1229_bib39","doi-asserted-by":"crossref","first-page":"941921","DOI":"10.1155\/2012\/941921","article-title":"Review of diagnostic imaging modalities for the surveillance of melanoma patients","volume":"2012","author":"Xing","year":"2012","journal-title":"Dermatol Res Pract"},{"issue":"5","key":"10.1016\/j.jaad.2016.02.1229_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/CMR.0b013e328348dad3","article-title":"Lymph node ultrasound during melanoma follow-up significantly improves metastasis detection compared with clinical examination alone: a study on 433 patients","volume":"21","author":"Kr\u00fcger","year":"2011","journal-title":"Melanoma Res"},{"issue":"11 Suppl","key":"10.1016\/j.jaad.2016.02.1229_bib41","first-page":"1","article-title":"Malignant melanoma S3-guideline \u201cdiagnosis, therapy and follow-up of melanoma.\u201d","volume":"6","author":"Pflugfelder","year":"2013","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216014961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216014961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:39:55Z","timestamp":1759271995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216014961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0190962216014961"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1229","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}